Aspartame (SC-18862, 3-amino-N-(a-carboxyphenethyl)succinarnic acid, methyl ester; the methyl ester of aspartyl-phenylalanine ) is a sweetening agent that organoleptically has about 180 times the sweetness of sugar. Because it so closely resembles naturally occurring dipeptides, it was believed that it would be digested in a similar manner. To show this, the metabolism of [14C]aspartame labeled separately in the methyl, aspartyl and phenylalanine moieties was compared with the metabolism of "C-labeled methanol, aspartic acid, and phenylalanine. The metabolism of each moiety of aspartame was found to be the same as its free counterpart. Parameters measured were: conversion to "COj, incorporation of 14C into plasma proteins, and urinary and fecal excretion of the label. It was concluded that aspartame was digested to its three constituents that were then absorbed as natural constituents of the diet.
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Aspartame (SC-18862, 3-amino-N-(a-carboxyphenethyl)succinamic acid, methyl ester; the methyl ester of aspartyl-phenyl alanine ) is a sweetening agent that organoleptically has about 180 times the sweet ness of sugar ( 1 ) . In considering the metab olism of this dipeptide, it is evident that extensive degradation of the compound may occur after it enters the digestive tract. The compound is stable in an acid medium and would be expected to be little changed by the gastric juice. However, in the small intestine chymotrypsin would be expected to hydrolyze the methyl group (2) , and the peptide hydrolases of the microvillar membrane would cleave the dipeptide to its constituent amino acids ( 3 ) . If this were the case, then all moieties of the compound, methanol, phenylalanine, and aspartic acid, should be handled by the body as natural constituents of the diet.
Dietary methanol is derived in large part from fresh fruits and vegetables. It occurs as the free alcohol or esterified with fatty acids, or as the product resulting from the hydrolysis of methoxy groups of polysaccharides such as pectin (4) (5) (6) (7) . In fruit juices the methanol content may range from 12 to 640 mg/liter with an average of 140 mg/liter (7). Dietary methanol is metabolized in the body primarily to COL. in the one-carbon metabolic pool (8, 9) , although some may be excreted unchanged in the breath (10) .
Dietary phenylalanine is derived from ingested protein. Absorbed phenylalanine not only is incorporated directly into pro tein, but also is metabolized via tyrosine, homogentisate, and fumaryl acetoacetate to CO;, via the tricarboxylic acid cycle (11) .
The aspartic acid in the diet is also de rived from ingested protein. Aspartate is rapidly converted to CO2 after deamination and entrance into the tricarboxylic cycle via oxaloacetate. It is incorporated into pro tein, and it also enters into purine and pyrimidine biosynthesis via carbamyl aspartate(ll).
To verify the hypothetical metabolism of aspartame proposed above, studies of its metabolism were begun by investigating the pharmacokinetics of the separate moie ties labeled with "C in order to see how the monkey handled methanol, aspartic acid, and phenylalanine. A comparison of the metabolism'of ["Clmethyl, fl4Clphe-nylalanine, and [14C]aspartyl labeled aspartame with these base lines demonstrated the correctness of our hypothesis. These labeled moieties of the sweetener were metabolized in the same fashion and to the same extent as the free compounds. The only differences noted were the rates of metabolism, and these were attributed to the finite time needed for gastric emptying, cleavage of the ester bond, and hydrolysis of the dipeptide to its constituent amino acids.
METHODS
Treatment of animals. Young female rhesus monkeys (3 to 7 kg) fed ad libitum 1 were utilized in these studies. Labeled compounds were administered orally at the dose of 0.068 mmoles/kg (10 to 50 /Â¿Ci/ dose). Animals given [asp-14C]aspartame or [14C|aspartic acid were pretreated for 5 days with unlabeled compounds. Before treatment, each animal was sedated with 1 mg/kg phencyclidine hydrochloride. A Teflon catheter-( 18G, 2.5 inches) was inserted into a saphenous vein. After catheterization each animal was placed in a primate chair, and [14C]aspartame or a 14C-labeled compound was administered by oral intubation. Immediately after admin istration of the labeled compound, a plastic helmet was placed over each monkey's head; and, by means of a vacuum, room air (approximately 15 liters/minute) was drawn through the helmet and through three consecutive gas washers each con taining 100 ml of ethanolamine:methylcellusolve (1:2). After 7 to 10 hours of 14CO2 collection, the animals were removed from the primate chairs and were transferred to stainless steel metabolism cages from which urine and feces were collected. The exact times of collection in each study are given in the figure legends.
Plasma 14C.Blood samples were obtained at each time interval by withdrawal through the catheter and were placed in test tubes containing a small quantity of heparin. The catheter was maintained patent by periodi cally flushing it with a small quantity of heparin solution ( 1 mg/ml ). Blood samples collected after 12 hours were obtained by venous puncture.
After centrifugation of the whole blood, plasma was assayed for radioactivity by adding 0.1-ml or 0.2-ml aliquots to 15 ml of Bray's scintillation fluid (12) , and the 14C was measured in a liquid scintillation spectrometer.3 14CO2. At each time interval the con tents of three gas washers were pooled, the volume was determined, a 0.5-ml aliquot was added to 20 ml of scintillation fluid 16.4 g of 2,5-diphenyloxazole, 0.16 g of l,4-bis-2-( 5-phenyloxazolyl )-benzene, 0.564 liter of ethanol, 1 liter of toluene], and the radioactivity was determined.
Urinary "C. Urinary radioactivity was determined by adding 0.5 ml of undiluted urine to 20 ml of Bray s scintillation mixture ( 12 ) for liquid scintillation spectrometry.
Fecal 14C. Fecal samples were homoge nized in water and lyophilized. An aliquot of this dry powder was combusted to COa in a sample oxidizer. 4 The CO2 trappingscintillation mixture was composed of 5 ml of ethanolamine, 9 ml of methanol, and 5 ml of scintillation solution [15 g of 2,5-diphenyloxazole, l g of ;j-bis-(O-methylstynyl)-benzene; dissolved in 1 liter of toluene]. All radioactivity measurements were counted to Â±1% accuracy and were corrected for background and counting ef ficiency by an external standard method. figure 1 the cumulative expired 14CO2 is plotted after oral administration of equimolar amounts of either [14C]methanol or [Me-14C]aspartame. It can be seen that the conversion of administered 14C to respiratory "COz oc curred to the same extent with both com pounds. This suggests that the methyl moiety was rapidly and completely cleaved from aspartame. Furthermore, it appears that the methyl group of aspartame was oxidized to the same extent as methanol. However, during the first hour after aspar tame administration, there was little 14CO2 expired, whereas 14CO2output after metha nol treatment was very rapid. This differ ence may be explained by ready absorption of methanol from the stomach, while as partame must have had to pass into the small intestine before hydrolysis and ab sorption occurred.
RESULTS

Methanol metabolism. In
In figure 2 the plasma levels of "C fol lowing [14C]methanol or [Me-14C]aspartame are shown. It can be seen that with both compounds the plasma levels of "C were low and that the disappearance of radioactivity was slow. Furthermore, with aspartame the rate of decline of radio activity appeared to change with time. This may be due to the incorporation of the label into two or more metabolic pools, each of which had a different turnover time. Figure 2 also illustrates the delay in the absorption of the label after adminis tration of aspartame.
In the 8-hour period that followed the administration of [14C]methanol, 73.0 Â± 3.1% (mean Â± SEM) of the 14C was ex creted in the expired air, 3.17 Â±0.31% was excreted in the urine, and there was little radioactivity in the feces. During the same period after [Me-14C]aspartame treatment, 67.1 Â±2.1% of the "C was found in the expired air, 1.57 Â±0.32% was in the urine, and the 14Cin the feces was negligible.
Phenylalanine metabolism. In figure 3 puniteci into a metabolic pool with a slow turnover time. This, therefore, could rep resent the incorporation of the labeled phenylalanine moiety into plasma proteins and other natural body constituents.
In the 7-hour period that followed the administration of ["CJphenylalanine, 17.9 Â±3.0% of the label was excreted as "CO2. In a 48-hour collection period 3.10 Â±0.75% appeared in the urine, and 4.71 Â±1.3% was in the feces. During the same periods after treatment with |Phe-14C|aspartame, 17.4 Â±2.1% of the 14C was found in the expired air, 2.79 Â±0.41% was in the urine, and 1.57 Â±0.71 % was in the feces.
Aspartic acid metabolism. In figure 5 are shown the cumulative expired 14CO^values after oral administration of |14C|aspartic acid or [Asp-"C|aspartame.
The |Asp-"Cjaspartame values at early times were less than those for the free amino acid, but the totals of 14C excreted were similar for each group of animals.
In figure 6 mean plasma 14C levels after the administration of [Asp-14C|aspartame and ["CJaspartic acid are shown. Consid erable individual variations in the plasma radioactivity levels were observed among animals in each treatment group at early time points. This was also evident in the 14COo excretion and probably reflects dif ferences among the overall physiological states of the animals.
The mean plasma 14Ccurves appeared to be biphasic with both compounds. In ad dition, the terminal portions of the curves were nonlinear. Incorporation of aspartic acid into plasma proteins may account for both the biphasic phenomena as well as the nonlinearity of the curves.
In the 10-hour period that followed the administration of [Asp-14C]aspartame, 74.7 Â±3.9% of the 14C was excreted as "CO2; and in the 4 days following this treatment, 2.12 Â±0.38% was excreted in the urine, and 1.63 Â±0.36%) was detected in the feces. After [''C] aspartic acid was given, 65.8 Â±1.9% of the label was found in "CO2; and during 4 days, 3.80 Â±0.12% was excreted in the urine, and 1.51 Â±0.32% was in the feces.
DISCUSSION
These data provide evidence that sup ports the hypothesis that aspartame was hydrolyzed in the gut of the monkey to release its separate moieties for metabolism by normal metabolic pathways. Irrespective of its source as free [14C]methanol or [Me-14C]aspartame, the label was rapidly ab sorbed, oxidized, and excreted in the ex pired air as 14CC>2. That fraction not so excreted (about 30%) was converted to body constituents through the one-carbon metabolic pool. This interpretation is sup ported by the slow disappearance of 14C from the plasma. In this case the label had The phenylalanine moiety of aspartame followed the same metabolic pathways as the free amino acid. Studies in the dog5 have demonstrated that unhydrolyzed as partame cannot be detected in the plasma. The formation of 14CO2 from [Phe-14C|as-partame was the same as that from [14C] phenylalanine and appeared to occur after obligate hydrolysis of the dipcptide before absorption. The amounts of radioactivity incorporated into plasma protein were the same when either labeled compound was administered.
The metabolic transformations of aspartic acid are complex; however, the major path way for free aspartic acid is the conver sion to oxaloacetic acid via transamination (11) . The entrance of this latter compound (uniformly labeled in this case) into the tricarboxylic acid cycle results in 50% of the label being lost as "CO^in one com plete pass through the cycle. The similarity in the rates and amounts of 14CO2excretion following | Asp-14C]aspartame or [14C|as partic acid administration suggests that free aspartic acid was rapidly produced from the ingested aspartame. Equal amounts of 14C from the two labeled com pounds were incorporated into plasma proteins.
Since the phenylalanine derived from aspartame was incorporated into body pro tein to a great extent, the following study ( 13 ) was carried out to determine if con tinued ingestion of aspartame had any ef fect on phenylalanine metabolic parameters.
